Dr. Kai Sun, MD

Dr. Sun practices at Houston Methodist Hospital in Houston, Texas, part of Houston Methodist.

Dr. Sun's NPI, 1841746112, was assigned on August 28, 2016. Dr. Sun graduated from Qingdao University Medical College in 2013. Dr. Sun holds Texas license T4470.

Dr. Sun's primary practice is Houston Methodist Hospital, at 6565 Fannin, Houston, TX 77030 in Harris County. The practice phone is (713) 790-2221.

Dr. Sun's primary practice is Houston Methodist Hospital in Houston, Texas, part of Houston Methodist. Dr. Sun is also affiliated with Houston Methodist West Hospital. The medical group on file is Houston Methodist Specialty Physician Group. Dmand AI also links Dr. Sun to 3 more hospitals, 1 skilled nursing facility and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sun practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Sun's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Sun is board certified in hematology by the American Board of Internal Medicine. Dr. Sun is licensed in Texas.

Dmand AI lists breast cancer and lung cancer among the conditions Dr. Sun treats.

CMS data shows 259 Medicare services from Dr. Sun across 5 procedure codes in 2024, for 116 Medicare patients. Medicare paid $25,763 for them.

CMS counts 116 Medicare patients who saw Dr. Sun in 2024. The largest group is 65 to 74, with 71 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sun's median patient age at 69, with 94% women.

In 2024, Dr. Sun wrote 438 Medicare Part D claims for 123 patients. 89% of them were for generic drugs. CMS names the drug for 343 of them, across 9 drugs with 11 or more claims each, at $575,428 in total drug cost. In 2023, CMS named 58 claims across 2 drugs.

Dr. Sun accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sun as offering telehealth.

Dmand AI links 27 papers to Dr. Sun, published from 2011 to 2024. 2022 was the busiest year, with 3. The most frequent topics are Adipose Tissue, Killer Cells, Natural and Obesity. Dr. Sun has published most often in Appl Opt. Dr. Sun's most frequent co-authors are Bruce Robert Blazar, MD, Mingyi Chen, MD and Vatche Garen Agopian, MD.

CMS Open Payments shows 6 general payments to Dr. Sun from 5 drug and device companies from 2022 to 2025. Education make up the largest share, 61% of the total. AstraZeneca Pharmaceuticals LP paid the most, $68.

Dr. Sun graduated from Qingdao University Medical College in 2013.

Dr. Sun is in network with 10 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.